Medicine and Dentistry
Intensive Care Unit
62%
Pediatrics
45%
Intensive Care
43%
Sepsis
31%
Hemodynamic
27%
Observational Study
27%
Infection
23%
Endothelial Cell
22%
Randomized Controlled Trial
22%
Propofol
21%
Heart Surgery
21%
Acute Respiratory Distress Syndrome
21%
Artificial Respiration
20%
COVID-19
19%
Cohort Analysis
18%
Systematic Review
18%
Disease
15%
General Anesthesia
14%
Remifentanil
14%
Quality of Life
14%
Acute Kidney Injury
13%
Diagnosis
13%
Bispectral Index
13%
Drug Therapy
13%
Injury
13%
Resuscitation
12%
Infusion
12%
ST Segment Elevation Myocardial Infarction
12%
Emergency Department
12%
Antibiotics
11%
Pharmacokinetics
11%
Clinician
10%
Hypotension
10%
In Vitro
10%
Respiratory Failure
10%
Extracorporeal Membrane Oxygenation
10%
Kidney Graft
9%
Shock (Circulatory)
9%
Meta-Analysis
9%
Machine Perfusion
9%
Septic Shock
9%
Pharmacodynamics
8%
Continuous Positive Airway Pressure
8%
Randomized Clinical Trial
8%
Cardiopulmonary Bypass
8%
Target-Controlled Infusion
8%
Clinical Trial
8%
near Infrared Spectroscopy
8%
Biological Marker
8%
Acute Lung Injury
8%
Mean Arterial Pressure
8%
Heart Output
8%
Health Care Cost
8%
Hemodynamic Monitoring
8%
Cardiovascular System
8%
Prospective Cohort Study
8%
Blood Pressure
8%
Kidney Function
7%
Coronary Artery Bypass Graft
7%
Bleeding
7%
Serositis
7%
Placebo
7%
Brain Ischemia
7%
Intensive Care Medicine
7%
Hypoxia
7%
Neoplasm
7%
Adverse Event
7%
Apoplexy
7%
Heart Arrest
7%
Anemia
7%
Positron Emission Tomography-Computed Tomography
7%
Oxygen Saturation
7%
Sevoflurane
7%
Anesthesiologist
7%
Breathing
7%
Volunteer
7%
Erythrocyte
7%
Glycon
7%
Subarachnoid Hemorrhage
6%
Neonate
6%
Antibiotic Therapy
6%
Perioperative Period
6%
Symptom
6%
Endothelial Leukocyte Adhesion Molecule 1
6%
Pathophysiology
6%
Therapeutic Drug Monitoring
6%
Arterial Pressure
6%
Anesthetic Agent
6%
Tidal Volume
6%
Myocardial Infarction
6%
Traumatic Brain Injury
6%
Hospital Mortality
6%
Odds Ratio
6%
Acute Heart Infarction
6%
Retrospective Cohort Study
6%
Kidney Transplantation
6%
Deterioration
5%
Antiinfective Agent
5%
Lactic Acid
5%
Low Back Pain
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Pharmacodynamics
31%
Therapeutic Drug Monitoring
30%
Sepsis
26%
Cystic Fibrosis
22%
Propofol
21%
Infection
19%
Disease
18%
ST Segment Elevation Myocardial Infarction
16%
Tobramycin
15%
Randomized Controlled Trial
15%
Normal Human
15%
Cohort Study
14%
Acute Kidney Failure
13%
Inflammation
12%
Placebo
12%
Antibiotics
12%
Toxic Injury
12%
Observational Study
11%
Mouse
10%
Neoplasm
10%
Adverse Event
10%
Remifentanil
10%
Clinical Trial
9%
Metformin
9%
Antibiotic Agent
9%
Tumor Necrosis Factor
9%
Receptor
9%
Antiinfective Agent
8%
Adult Respiratory Distress Syndrome
8%
Subarachnoid Hemorrhage
8%
Staphylococcus Aureus
8%
Heart Failure
7%
Cytokine
7%
Prevalence
7%
Lipopolysaccharide
7%
Randomized Clinical Trial
7%
Brain Ischemia
7%
Anesthetic Agent
7%
Symptom
7%
Drug Concentration
7%
Injury
6%
Biological Marker
6%
Pharmacokinetics
6%
Infarction
6%
Rocuronium
6%
Pharmacotherapy
6%
Malignant Neoplasm
6%
Prospective Cohort Study
6%
Heart Infarction
6%
Hypotension
6%
Volume of Distribution
6%
Side Effect
6%
Hemodialysis
6%
Acute Heart Infarction
6%
Midazolam
6%
Pharmacogenetics
6%
Small Interfering RNA
6%
Paracetamol
5%
Clinical Study
5%
E-Selectin
5%
Dexamethasone
5%
Liposome
5%
Creatinine
5%
Pharmacokinetic Parameter
5%
Pharmacokinetic Modeling
5%
Dexmedetomidine
5%
All Cause Mortality
5%
Drug Interaction
5%
Neuromuscular Blocking Agent
5%
Pharmacodynamic Modeling
5%
Aminoglycoside
5%
Vascular Cell Adhesion Molecule 1
5%
Tolerability
5%
Non Insulin Dependent Diabetes Mellitus
5%
Keyphrases
Pharmacokinetics
24%
Critically Ill Patients
17%
Intensive Care Unit
17%
Therapeutic Drug Monitoring
13%
Netherlands
10%
Confidence Interval
9%
Intensive Care Unit Patients
9%
Cardiac Surgery
9%
Sepsis
8%
Cystic Fibrosis
8%
COVID-19
8%
Anesthesia
7%
Tobramycin
7%
Prospective Cohort Study
7%
Randomized Controlled Trial
6%
Kidney Transplant Recipients
6%
Emergency Department
6%
Aneurysmal Subarachnoid Hemorrhage (aSAH)
6%
ST-elevation Myocardial Infarction (STEMI)
6%
Healthy Volunteers
6%
Health-related Quality of Life
6%
Prospective Observational Study
6%
Dutch
5%
Pediatric Intensive Care Unit
5%
Acute Kidney Injury
5%
Pharmacodynamics
5%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
5%
Delayed Cerebral Ischemia
5%
Intensive Care
5%
Placebo
5%
Transplantation
5%
Propofol
5%